Evaluation of high functional avidity CTL to Gag epitope clusters in EIAV carrier horses

Virology

Volumn 342, Issue 2, 2005, Pages 228-239

  Chung, Chungwon ^a,b   Mealey, Robert H ^a   McGuire, Travis C ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Capsid; CTL; EIAV; Epitope cluster; Functional avidity; Gag; Lentivirus; Matrix

Indexed keywords

EPITOPE; GAG PROTEIN;

ARTICLE; CORRELATION ANALYSIS; CYTOTOXIC T LYMPHOCYTE; DISEASE DURATION; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; LENTIVIRINAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS CAPSID; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; CAPSID PROTEINS; CARRIER STATE; EPITOPES, T-LYMPHOCYTE; EQUINE INFECTIOUS ANEMIA; GENE PRODUCTS, GAG; HORSES; INFECTIOUS ANEMIA VIRUS, EQUINE; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; EQUUS CABALLUS; LENTIVIRUS; MIRIDAE;

EID: 27644514704     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2005.07.033     Document Type: Article

References (56)

1. M.A. Alexander-Miller, G.R. Leggatt, and J.A. Berzofsky Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy Proc. Natl. Acad. Sci. U.S.A. 93 1996 4102 4107
2. L.C. Anton, J.W. Yewdell, and J.R. Bennink MHC class I-associated peptides produced from endogenous gene products with vastly different efficiencies J. Immunol. 158 1997 2535 2542
3. E. Bailey, E. Marti, D.G. Fraser, D.F. Antczak, and S. Lazary Immunogenetics of the Horse A.T. Bowling A. Ruvinsky The Genetics of the Horse 2000 CABI Publishing Inc UK 123 155
4. D. Bernoco, G. Byrns, E. Bailey, and A.M. Lew Evidence of a second polymorphic ELA class I (ELA-B) locus and gene order for three loci of the equine major histocompatibility complex Anim. Genet. 18 1987 103 118
5. S. Carpenter, L.H. Evans, M. Sevoian, and B. Chesebro Role of the host immune response in selection of equine infectious anemia virus variants J. Virol. 61 1987 3783 3789
6. R. Chenna, H. Sugawara, T. Koike, R. Lopez, T.J. Gibson, D.G. Higgins, and J.D. Thomson Multiple sequence alignment with the Clustal series of programs Nucleic Acids Res. 31 2003 3497 3500
7. C. Chung, S.R. Leib, D.G. Fraser, S.A. Ellis, and T.C. McGuire Novel classical MHC class I alleles identified in horses by sequencing clones of reverse transcription-PCR products Eur. J. Immunogenet. 30 2003 387 396
8. C. Chung, R.H. Mealey, and T.C. McGuire CTL from EIAV carrier horses with diverse MHC class I alleles recognize epitope clusters in Gag matrix and capsid proteins Virology 327 2004 144 154
9. L. Coggins Carriers of equine infectious anemia virus J. Am. Vet. Med. Assoc. 184 1984 279 281
10. R.F. Cook, S.J. Cook, F.L. Li, R.C. Montelaro, and C.J. Issel Development of a multiplex real-time reverse transcriptase-polymerase chain reaction for equine infectious anemia virus (EIAV) J. Virol. Methods 105 2002 171 179
11. M. Dalod, M. Dupuis, J.C. Deschemin, D. Sicard, D. Salmon, J.F. Delfraissy, A. Venet, M. Sinet, and J.G. Guillet Broad, intense anti-human immunodeficiency virus (HIV) ex vivo CD8(+) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy J. Virol. 73 1999 7108 7116
12. M. Derby, M. Alexander-Miller, R. Tse, and J. Berzofsky High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL J. Immunol. 166 2001 1690 1697
13. T. Dorfman, A. Burkovsky, A. Ohagen, and S. Hoglund Functional domains of the capsid protein of human immunodeficiency virus type 1 J. Virol. 68 1994 8180 8187
14. S. Ehl, P. Klenerman, P. Aichele, H. Hengartner, and R.M. Zinkernagel A functional and kinetic comparison of antiviral effector and memory cytotoxic T lymphocyte populations in vivo and in vitro Eur. J. Immunol. 27 1997 3404 3413
15. T.C. Friedrich, C.A. Frye, L.J. Yant, D.H. O'Connor, N.A. Kriewaldt, M. Benson, L. Vojnov, E.J. Dodds, C. Cullen, R. Rudersdorf, A.L. Hughes, N. Wilson, and D.I. Watkins Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response J. Virol. 78 2004 2581 2585
16. A. Gallimore, T. Dumrese, H. Hengartner, R.M. Zinkernagel, and H.G. Rammensee Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides J. Exp. Med. 187 1998 1647 1657
17. R.K. Gitti, B.M. Lee, J. Walker, M.F. Summers, S. Yoo, and W.I. Sundquist Structure of the amino acid terminal core domain of the HIV-1 capsid protein Science 273 1996 231 235
18. P.J. Goulder, and D.I. Watkins HIV and SIV CTL escape: implications for vaccine design Nat. Rev., Immunol. 4 2004 630 640
19. P.M. Gray, G.D. Parks, and M.A. Alexander-Miller A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5 J. Virol. 75 2001 10065 10072
20. S.A. Hammond, S.J. Cook, D.L. Lichtenstein, C.J. Issel, and R.C. Montelaro Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process J. Virol. 71 1997 3840 3852
21. S.A. Hammond, F. Li, B.M. McKeon Sr., S.J. Cook, C.J. Issel, and R.C. Montelaro Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus J. Virol. 74 2000 5968 5981
22. K.A. Hussain, C.J. Issel, K.L. Schnorr, P.M. Rwambo, and R.C. Montelaro Antigenic analysis of equine infectious anemia virus (EIAV) variants by using monoclonal antibodies: epitopes of glycoprotein gp90 of EIAV stimulate neutralizing antibodies J. Virol. 61 1987 2956 2961
23. A.D. Kelleher, C. Long, E.C. Holmes, R.L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, C. Brander, G. Ogg, J.S. Sullivan, W. Dyer, I. Jones, A.J. McMichael, S. Rowland-Jones, and R.E. Phillips Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses J. Exp. Med. 193 2001 375 386
24. Y. Kono, K. Kobayashi, and Y. Fukunaga Antigenic drift of equine infectious anemia virus in chronically infected horses Arch. Gesamte Virusforsch. 41 1973 1 10
25. Y. Kono, K. Hirasawa, Y. Fukunaga, and T. Taniguchi Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs Natl. Inst. Anim. Health Q. (Tokyo) 16 1976 8 15
26. M.J. Kuroda, J.E. Schmitz, W.A. Charini, C.E. Nickerson, M.A. Lifton, C.I. Lord, M.A. Forman, and N.L. Letvin Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys J. Immunol. 162 1999 5127 5133
27. S. Lazary, D.F. Antczak, E. Bailey, T.K. Bell, D. Bernoco, G. Byrns, and J.J. McClure Joint report of the Fifth International Workshop on Lymphocyte Alloantigens of the Horse, Baton Rouge, Louisiana, 31 October-1 November 1987 Anim. Genet. 19 1988 447 456
28. C.M. Leutenegger, J. Higgins, T.B. Matthews, A.F. Tarantal, P.A. Luciw, N.C. Pedersen, and T.W. North Real-time TaqMan PCR as a specific and more sensitive alternative to the branched-chain DNA assay for quantitation of simian immunodeficiency virus RNA AIDS Res. Hum. Retroviruses 17 2001 243 251
29. T. Matano, M. Kobayashi, H. Igarashi, A. Takeda, H. Nakamura, M. Kano, C. Sugimoto, K. Mori, A. Iida, T. Hirata, M. Hasegawa, T. Yuasa, M. Miyazawa, Y. Takahashi, M. Yasunami, A. Kimura, D.H. O'Connor, D.I. Watkins, and Y. Nagai Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial J. Exp. Med. 199 2004 1709 1718
30. T.C. McGuire, D.B. Tumas, K.M. Byrne, M.T. Hines, S.R. Leib, A.L. Brassfield, K.I. O'Rourke, and L.E. Perryman Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins J. Virol. 68 1994 1459 1467
31. T.C. McGuire, S.R. Leib, S.M. Lonning, W. Zhang, K.M. Byrne, and R.H. Mealey Equine infectious anaemia virus proteins with epitopes most frequently recognized by cytotoxic T lymphocytes from infected horses J. Gen. Virol. 81 2000 2735 2739
32. R.H. Mealey, D.G. Fraser, J.L. Oaks, G.H. Cantor, and T.C. McGuire Immune reconstitution prevents continuous equine infectious anemia virus replication in an Arabian foal with severe combined immunodeficiency: lessons for control of lentiviruses Clin. Immunol. 101 2001 237 247
33. R.H. Mealey, B. Zhang, S.R. Leib, M.H. Littke, and T.C. McGuire Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus Virology 313 2003 537 552
34. C. Momany, L.C. Kovari, A.J. Prongay, W. Keller, R.K. Gitti, B.M. Lee, A.E. Gorbalenya, L. Tong, J. McClure, L.S. Ehrlich, M.F. Summers, C. Carter, and M.G. Rossmann Crystal structure of dimeric HIV-1 capsid protein Nat. Struct. Biol. 3 1996 763 770
35. R.C. Montelaro, J.M. Ball, and K.E. Rushlow Equine retroviruses J.A. Levy The Retroviridae 1993 Plenum Press New York, NY 257 360
36. R.C. Montelaro, B. Parekh, A. Orrego, and C.J. Issel Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus J. Biol. Chem. 259 1984 10539 10544
37. V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M.F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, T.H. Lee, and M. Essex Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C J. Virol. 76 2002 10155 10168
38. M.A. Nowak, R.M. May, R.E. Phillips, S. Rowland-Jones, D.G. Lalloo, S. McAdam, P. Klenerman, B. Koppe, K. Sigmund, C.R.M. Bangham, and A.J. McMichael Antigenic oscillations and shifting immunodominance in HIV-1 infections Nature 375 1995 606 611
39. D.H. O'Connor, T.M. Allen, T.U. Vogel, P. Jing, I.P. DeSouza, E. Dodds, E.J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, H. Horton, N. Wilson, A.L. Hughes, and D.I. Watkins Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection Nat. Med. 8 2002 493 499
40. G.S. Ogg, X. Jin, S. Bonhoeffer, P.R. Dunbar, M.A. Nowak, S. Monard, J.P. Segal, Y. Cao, S.L. Rowland-Jones, V. Cerundolo, A. Hurley, M. Markowitz, D.D. Ho, D.F. Nixon, and A.J. McMichael Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA Science 279 1998 2103 2106
41. K. O'Rourke, L.E. Perryman, and T.C. McGuire Antiviral, anti-glycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus J. Gen. Virol. 69 1988 667 674
42. L.E. Perryman, K.I. O'Rourke, and T.C. McGuire Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection J. Virol. 62 1988 3073 3076
43. M.L. Raabe, C.J. Issel, S.J. Cook, R.F. Cook, B. Woodson, and R.C. Montelaro Immunization with a recombinant envelope protein (rgp90) of EIAV produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement Virology 245 1998 151 162
44. P.M. Rwambo, C.J. Issel, K.A. Hussain, and R.C. Montelaro In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV) Arch. Virol. 111 1990 275 280
45. J.E. Schmitz, M.J. Kuroda, S. Santra, V.G. Sasseville, M.A. Simon, M.A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B.J. Scallon, J. Ghrayeb, M.A. Forman, D.C. Montefiori, E.P. Rieber, N.L. Letvin, and K.A. Reimann Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes Science 283 1999 857 860
46. D.C. Sellon, F.J. Fuller, and T.C. McGuire The immunopathogenesis of equine infectious anemia virus Virus Res. 32 1994 111 138
47. R.F. Siliciano, A.D. Keegan, R.Z. Dintzis, H.M. Dintzis, and H.S. Shin The interaction of nominal antigen with T cell antigen receptors: I. Specific binding of multivalent nominal antigen to cytolytic T cell clones J. Immunol. 135 1985 906 914
48. J.W. Sleasman, and M.M. Goodenow 13. HIV-1 infection J. Allergy Clin. Immunol. 111 2003 S582 S592
49. D.E. Speiser, D. Kyburz, U. Stubi, H. Hengartner, and R.M. Zinkernagel Discrepancy between in vitro measurable and in vivo virus neutralizing cytotoxic T cell reactivities. Low T cell receptor specificity and avidity sufficient for in vitro proliferation or cytotoxicity to peptide-coated target cells but not for in vivo protection J. Immunol. 149 1992 972 980
50. P.I. Terasaki, D. Bernoco, M.S. Park, G. Ozturk, and Y. Iwaki Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture Am. J. Clin. Pathol. 69 1978 103 120
51. S.Z. Wang, K.E. Rushlow, C.J. Issel, R.F. Cook, S.J. Cook, M.L. Raabe, Y.H. Chong, L. Costa, and R.C. Montelaro Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein Virology 199 1994 247 251
52. T. Woodberry, J. Gardner, L. Mateo, D. Eisen, J. Medveczky, I.A. Ramshaw, S.A. Thomson, R.A. Ffrench, S.L. Elliott, H. Firat, F.A. Lemonnier, and A. Suhrbier Immunogenicity of a human immunodeficiency virus (HIV) polytope vaccine containing multiple HLA A2 HIV CD8(+) cytotoxic T-cell epitopes J. Virol. 73 1999 5320 5325
53. C.R. Wyatt, W.C. Davis, T.C. McGuire, and L.E. Perryman T lymphocyte development in horses: I. Characterization of monoclonal antibodies identifying three stages of T lymphocyte differentiation Vet. Immunol. Immunopathol. 18 1988 3 18
54. O.O. Yang, P.T. Sarkis, A. Trocha, S.A. Kalams, R.P. Johnson, and B.D. Walker Impacts of avidity and specificity on the antiviral efficiency of HIV-1-specific CTL J. Immunol. 171 2003 3718 3724
55. W.H. Zhang, D. Hockley, M.V. Nermut, Y. Morikawa, and I.M. Jones Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly J. Gen. Virol. 77 1996 743 751
56. W. Zhang, S.M. Lonning, and T.C. McGuire Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection J. Virol. 72 1998 9612 9620